Prompt versus Delayed Triple Therapy in COPD: Solutions to Time-Related Biases in Observational Studies

Area of Science:

• Pulmonary Medicine
• Clinical Epidemiology
• Health Informatics

Background:

• Observational studies suggest prompt single-inhaler triple therapy post-COPD exacerbation improves outcomes.
• Concerns exist regarding time-related biases, such as protopathic bias, in these observational designs.
• Trial emulation using a "cloning" approach can mitigate these biases.

Purpose of the Study:

• To evaluate the effectiveness of prompt versus delayed initiation of single-inhaler triple therapy after a COPD exacerbation.
• To address and correct for time-related biases present in previous observational studies.
• To emulate a randomized controlled trial design using real-world data.

Main Methods:

• A cohort of 91,958 patients with COPD exacerbations was identified from the UK Clinical Practice Research Datalink (CPRD).
• The "cloning" trial emulation technique assigned each patient to both prompt and delayed treatment arms.
• Cox proportional hazards models, weighted by inverse probability of censoring, compared subsequent exacerbation rates over one year.

Main Results:

• Prompt initiation of single-inhaler triple therapy showed no significant benefit over delayed initiation for moderate/severe exacerbations (HR: 0.98, 95% CI: 0.80-1.19).
• For severe exacerbations, prompt therapy was not more effective (HR: 1.26, 95% CI: 0.81-1.96).
• Replication of biased methods yielded significantly different results (HRs: 0.73 and 0.58), highlighting the impact of time-related biases.

Conclusions:

• Trial emulation suggests prompt single-inhaler triple therapy is not superior to delayed initiation for preventing subsequent COPD exacerbations.
• Previous findings of prompt therapy effectiveness were likely inflated due to time-related biases in study design.
• Further confirmation via randomized controlled trials is recommended to definitively establish optimal treatment timing.